Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants

被引:153
|
作者
Nan, Hongmei [1 ,2 ]
Hutter, Carolyn M. [3 ]
Lin, Yi [4 ]
Jacobs, Eric J. [5 ]
Ulrich, Cornelia M. [4 ,6 ]
White, Emily [4 ,7 ]
Baron, John A. [8 ]
Berndt, Sonja I. [9 ]
Brenner, Hermann [10 ,11 ]
Butterbach, Katja [10 ]
Caan, Bette J. [12 ]
Campbell, Peter T. [5 ]
Carlson, Christopher S. [4 ]
Casey, Graham [13 ]
Chang-Claude, Jenny [14 ]
Chanock, Stephen J. [9 ]
Cotterchio, Michelle [15 ]
Duggan, David [16 ]
Figueiredo, Jane C. [13 ]
Fuchs, Charles S. [17 ]
Giovannucci, Edward L. [18 ]
Gong, Jian [4 ]
Haile, Robert W. [13 ]
Harrison, Tabitha A. [4 ]
Hayes, Richard B. [19 ]
Hoffmeister, Michael [10 ]
Hopper, John L. [20 ]
Hudson, Thomas J. [21 ,22 ]
Jenkins, Mark A. [20 ]
Jiao, Shuo [4 ]
Lindor, Noralane M. [23 ]
Lemire, Mathieu [22 ]
Le Marchand, Loic [24 ]
Newcomb, Polly A. [4 ]
Ogino, Shuji [17 ,25 ,26 ]
Pflugeisen, Bethann M. [4 ]
Potter, John D. [4 ,27 ]
Qu, Conghui [4 ]
Rosse, Stephanie A. [4 ]
Rudolph, Anja [14 ]
Schoen, Robert E. [28 ]
Schumacher, Fredrick R. [13 ]
Seminara, Daniela [3 ]
Slattery, Martha L. [29 ]
Thibodeau, Stephen N. [30 ,31 ]
Thomas, Fridtjof [32 ]
Thornquist, Mark [4 ]
Warnick, Greg S. [4 ]
Zanke, Brent W. [33 ]
Gauderman, W. James [13 ]
机构
[1] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] NHGRI, NIH, Bethesda, MD 20892 USA
[4] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[5] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA
[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[7] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA
[8] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA
[9] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[10] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[11] German Canc Consortium DKTK, Heidelberg, Germany
[12] Kaiser Permanente Med Care Program No Calif, Div Res, Oakland, CA USA
[13] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[14] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[15] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada
[16] Translat Genom Res Inst TGen, Genet Basis Human Dis Div, Phoenix, AZ USA
[17] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[18] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA
[19] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA
[20] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia
[21] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[22] Ontario Inst Canc Res, Toronto, ON, Canada
[23] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA
[24] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA
[25] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[26] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[27] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand
[28] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA
[29] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA
[30] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[31] Mayo Clin, Dept Med Genet, Rochester, MN USA
[32] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Div Biostat & Epidemiol, Memphis, TN 38163 USA
[33] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
[34] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[35] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA
[36] Harvard Univ, Sch Med, Boston, MA USA
来源
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN E-2 BIOSYNTHESIS; COLON-CANCER; PIK3CA MUTATION; METAANALYSIS; CYCLOOXYGENASE-2; CHEMOPREVENTION; INTERLEUKIN-16; POLYMORPHISMS;
D O I
10.1001/jama.2015.1815
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with lower risk of colorectal cancer. OBJECTIVE To identify common genetic markers that may confer differential benefit from aspirin or NSAID chemoprevention, we tested gene x environment interactions between regular use of aspirin and/or NSAIDs and single-nucleotide polymorphisms (SNPs) in relation to risk of colorectal cancer. DESIGN, SETTING, AND PARTICIPANTS Case-control study using data from 5 case-control and 5 cohort studies initiated between 1976 and 2003 across the United States, Canada, Australia, and Germany and including colorectal cancer cases (n=8634) and matched controls (n=8553) ascertained between 1976 and 2011. Participants were all of European descent. EXPOSURES Genome-wide SNP data and information on regular use of aspirin and/or NSAIDs and other risk factors. MAIN OUTCOMES AND MEASURES Colorectal cancer. RESULTS Regular use of aspirin and/or NSAIDs was associated with lower risk of colorectal cancer (prevalence, 28% vs 38%; odds ratio [OR], 0.69 [95% Cl, 0.64-0.74]; P = 6.2 x 10(-28)) compared with nonregular use. In the conventional logistic regression analysis, the SNP rs2965667 at chromosome 12p12.3 near the MGST1 gene showed a genome-wide significant interaction with aspirin and/or NSAID use (P = 4.6 x 10(-9) for interaction). Aspirin and/or NSAID use was associated with a lower risk of colorectal cancer among individuals with rs2965667-TT genotype (prevalence, 28% vs 38%; OR, 0.66 [95% CI, 0.61-0.70]; P =7.7 x 10(-33)) but with a higher risk among those with rare (4%) TA or AA genotypes (prevalence, 35% vs 29%; OR, 1.89 [95% Cl, 1.27-2.81]; P = .002). In case-only interaction analysis, the SNP rs16973225 at chromosome 15q25.2 near the IL16 gene showed a genome-wide significant interaction with use of aspirin and/or NSAIDs (P = 8.2 x 10(-9) for interaction). Regular use was associated with a lower risk of colorectal cancer among individuals with rs16973225-AA genotype (prevalence, 28% vs 38%; OR, 0.66 [95% CI, 0.62-0.71]; P = 1.9 x 10(-30)) but was not associated with risk of colorectal cancer among those with less common (9%) AC or CC genotypes (prevalence, 36% vs 39%; OR, 0.97 [95% Cl, 0.78-1.20]; P = .76). CONCLUSIONS AND RELEVANCE In this genome-wide investigation of gene x environment interactions, use of aspirin and/or NSAIDs was associated with lower risk of colorectal cancer, and this association differed according to genetic variation at 2 SNPs at chromosomes 12 and 15. Validation of these findings in additional populations may facilitate targeted colorectal cancer prevention strategies.
引用
收藏
页码:1133 / 1142
页数:10
相关论文
共 50 条
  • [1] Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility
    Hurwitz, Lauren M.
    Webb, Penelope M.
    Jordan, Susan J.
    Doherty, Jennifer A.
    Harris, Holly R.
    Goodman, Marc T.
    Shvetsov, Yurii B.
    Modugno, Francesmary
    Moysich, Kirsten B.
    Schildkraut, Joellen M.
    Berchuck, Andrew
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Menon, Usha
    Ramus, Susan J.
    Wu, Anna H.
    Pearce, Celeste Leigh
    Wentzensen, Nicolas
    Tworoger, Shelley S.
    Pharoah, Paul D. P.
    Trabert, Britton
    [J]. JAMA NETWORK OPEN, 2023, 6 (02) : E230666
  • [2] Aspirin Use and Incidence of Colorectal Cancer According to Lifestyle Risk
    Sikavi, Daniel R.
    Wang, Kai
    Ma, Wenjie
    Drew, David A.
    Ogino, Shuji
    Giovannucci, Edward L.
    Cao, Yin
    Song, Mingyang
    Nguyen, Long H.
    Chan, Andrew T.
    [J]. JAMA ONCOLOGY, 2024,
  • [3] Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
    Nishihara, Reiko
    Lochhead, Paul
    Kuchiba, Aya
    Jung, Seungyoun
    Yamauchi, Mai
    Liao, Xiaoyun
    Imamura, Yu
    Qian, Zhi Rong
    Morikawa, Teppei
    Wang, Molin
    Spiegelman, Donna
    Cho, Eunyoung
    Giovannucci, Edward
    Fuchs, Charles S.
    Chan, Andrew T.
    Ogino, Shuji
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (24): : 2563 - 2571
  • [4] Aspirin Use and Risk of Colorectal Cancer According to Tumor Immunity Status
    Cao, Yin
    Nishihara, Reiko
    Qian, Zhi Rong
    Song, Mingyang
    Mima, Kosuke
    Inamura, Kentaro
    Nowak, Jonathan
    Drew, David
    Lochhead, Paul
    Nosho, Katsuhiko
    Morikawa, Teppei
    Zhang, Xuehong
    Wu, Kana
    Wang, Molin
    Garrett, Wendy
    Giovannucci, Edward
    Fuchs, Charles
    Ogino, Shuji
    Chan, Andrew T.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S211 - S211
  • [5] Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals
    Bakshi, Andrew
    Cao, Yin
    Orchard, Suzanne G.
    Carr, Prudence R.
    Joshi, Amit D.
    Manning, Alisa K.
    Buchanan, Daniel D.
    Umar, Asad
    Winship, Ingrid M.
    Gibbs, Peter
    Zalcberg, John R.
    Macrae, Finlay
    McNeil, John J.
    Lacaze, Paul
    Chan, Andrew T.
    [J]. CANCER PREVENTION RESEARCH, 2022, 15 (07) : 447 - 454
  • [6] Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer
    Viswanathan, Akila N.
    Feskanich, Diane
    Schernhammer, Eva S.
    Hankinson, Susan E.
    [J]. CANCER RESEARCH, 2008, 68 (07) : 2507 - 2513
  • [7] Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk
    Hofer, Philipp
    Baierl, Andreas
    Bernhart, Kathrin
    Leeb, Gernot
    Mach, Karl
    Micksche, Michael
    Gsur, Andrea
    [J]. MOLECULAR CARCINOGENESIS, 2012, 51 : E176 - E182
  • [8] The influence of NSAID use on colorectal cancer risk
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 (9): : 479 - 480
  • [9] Aspirin use and the risk of colorectal cancer according to cyclooxygenase-2 expression
    Chan, Andrew T.
    Ogino, Shoji
    Fuchs, Charles S.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A23 - A23
  • [10] Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians
    Wang, Nan
    Lu, Yingchang
    Khankari, Nikhil K.
    Long, Jirong
    Li, Hong-Lan
    Gao, Jing
    Gao, Yu-Tang
    Xiang, Yong-Bing
    Shu, Xiao-Ou
    Zheng, Wei
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) : 1130 - 1139